NovoCure (NVCR) reported 161.27millioninrevenueforthequarterendedDecember2024,representingayear−over−yearincreaseof20.60.61 for the same period compares to -0.45ayearago.Thereportedrevenuerepresentsasurpriseof−0.02161.3 million. With the consensus EPS estimate being -$0.34, the EPS surprise was -79.41%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to dete ...